 |
|||||
|
|
| Cool Links Directory // Business // Biotechnology and Pharmaceuticals |  |
|
|
Thu, 09 Feb 2012 05:00:00 -0800
Progress Across Four Business Units
Read More...
Tue, 07 Feb 2012 04:30:00 -0800
EMERYVILLE, Calif. -- NovaBay Pharmaceuticals, Inc. (NYSE Amex:NBY), a clinical stage biotechnology company developing its first-in-class, anti-infective Aganocide(R) compounds for the topical treatment ...
Read More...
Tue, 07 Feb 2012 04:00:00 -0800
Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, announced today that an overview of the Company’s business strategy will be given at the BIO CEO Investor Conference, being held at the Waldorf=Astoria Hotel in New York City.
Read More...
Thu, 09 Feb 2012 13:00:00 -0800
Alnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, today reported its consolidated financial results for the fourth quarter and full year 2011, and
Read More...
Mon, 06 Feb 2012 05:00:00 -0800
Synta Pharmaceuticals Corp. today announced that the Company will be presenting at the 2012 Biotechnology Industry Organization CEO & Investor Conference on Mond
Read More...
Fri, 27 Jan 2012 04:00:00 -0800
Spectrum Pharmaceuticals , a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the promotions of Rick Gonzalez to Senior Vice President, Commercial; Andrew W.
Read More...
Fri, 10 Feb 2012 13:00:00 -0800
Alnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, today announced that management will present a company overview at the 14th Annual BIO CEO & Investor Conference on Tuesday, February 14, 2012 at 3:30 p.m.
Read More...
Tue, 31 Jan 2012 09:31:00 -0800
The Biotechnology Industry Organization announces plenary sessions, Business Roundtables and Therapeutic Workshops selected for the 14th Annual BIO CEO & Investor Conference.
Read More...
Thu, 09 Feb 2012 05:00:00 -0800
Alnylam Pharmaceuticals, Inc. , a leading RNAi therapeutics company, announced today that its scientists have discovered a novel method for monitoring RNAi activity in blood samples, representing a potential major advance for future development of RNAi therapeutics, other therapeutic modalities, and diagnostics.
Read More...
Fri, 10 Feb 2012 08:38:00 -0800
Biopharm is gearing up for BIO-Europe Spring®, EBD Group’s springtime life science partnering conference in Amsterdam March 19–21, 2012 at the Amsterdam RAI Convention Center. BIO-Europe Spring attracts some of the best and brightest biotech companies in the sector, and the venture capital community has realized this opportunity by increasing their presence with more representatives this year.
Read More...
Home | Submit Link | Latest Links | Top Hits Powered by: Personalized Plastic Cups PHP Link Directory | Copyright 2008 , All rights reserved.